| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $237K | +147.7% |
| Cost of Revenue | $7K | -7.7% |
| R&D Expense | $11.5M | -31.6% |
| SG&A Expense | $9.5M | +49.1% |
| Operating Income | -$20.8M | +10.1% |
| Pre-tax Income | -$20.3M | +9.9% |
| Net Income | -$20.3M | +9.9% |
| EPS (Diluted) | -$0.16 | +15.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $69.0M | +149.4% |
| Accounts Receivable | $191K | +318.6% |
| Current Assets | $69.8M | +148.3% |
| Total Assets | $79.2M | +109.4% |
| Current Liabilities | $2.1M | +19.6% |
| Total Liabilities | $4.5M | +3.5% |
| Stockholders' Equity | $74.6M | +123.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$13.7M | +11.6% |
| Capital Expenditures | $1.3M | -41.3% |
| Investing Cash Flow | -$1.8M | +32.6% |
| Financing Cash Flow | $56.9M | +292.9% |
| Free Cash Flow | -$15.1M | +15.4% |